AC 3933

Known as: AC-3933, AC3933 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2016
012320042016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AC-3933, a novel benzodiazepine receptor partial inverse agonist, is a drug candidate for cognitive disorders including Alzheimer… (More)
Is this relevant?
2014
2014
GABAergic neurons are known to inhibit neural transduction and therefore negatively affect excitatory neural circuits in the… (More)
Is this relevant?
2014
2014
We have previously reported that AC-3933, a newly developed benzodiazepine receptor partial inverse agonist, facilitates… (More)
Is this relevant?
2014
2014
We investigated in this study the pharmacological properties of AC-3933 (5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1… (More)
Is this relevant?
2004
2004
5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine (AC-3933) is a novel cognitive enhancer… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2004
2004
OBJECTIVES Recently, we reported that AC-3933, a novel cognitive enhancer, is polymorphically hydroxylated in beagle dogs and… (More)
Is this relevant?